Phospho-Rpb1 CTD (Ser2) Antibody

Skip to product information
1 of 1

Selleck Chemicals

SKU:F0805-20UL

Regular price €189,00 EUR
Regular price Sale price €189,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

RNA polymerase II (RNAPII) is a complex multi-protein assembly responsible for transcribing DNA into RNA, utilizing ribonucleoside triphosphates as building blocks. Its largest subunit, RNAPII subunit B1 (Rpb1), also referred to as RNAPII subunit A (POLR2A), features a distinctive heptapeptide sequence (Tyr1,Ser2,Pro3,Thr4,Ser5,Pro6,Ser7), which repeats up to 52 times within the carboxy-terminal domain (CTD) of the protein. Depending on the literature source, POLR2A may also be discussed as Phospho-Rpb1 CTD (Ser2) and RNA polymerase II CTD repeat YSPTSPS (phospho S2).

Reported cellular context includes chromosome, cytoplasm, dna-directed rna polymerase, and nucleus, which can matter when signal is compared across treatments or changing cell states. Following POLR2A across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

POLR2A is commonly interpreted in the context of epigenetics and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans chromosome, cytoplasm, and dna-directed rna polymerase, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between chromosome, cytoplasm, and dna-directed rna polymerase across matched conditions
  • links between target behavior and transcriptional or chromatin-state changes
  • signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
  • differences between total target abundance and site-specific regulation when modified forms are compared

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for POLR2A. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in POLR2A reflect biology rather than handling. When interpreting POLR2A, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep POLR2A trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
POLR2A
Research Area:
Cell Signaling • Epigenetics
Application:
ChIP • IP • WB
Reactivity:
Human • Monkey • Mouse • Rat
Specificity:
Phospho-Rpb1 CTD (Ser2) Antibody [L19G24] recognizes endogenous levels of Rpb1 only when the carboxy-terminal domain (CTD) heptapeptide repeat [Tyr1, Ser2, Pro3, Thr4, Ser5, Pro6, Ser7] is phosphorylated at Ser2. This antibody does not cross-react with Rpb1 CTD phosphorylated at Ser5 or Ser7.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
L19G24
UniProt:
P24928
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.